Oklahoma recalls
3767 federal recalls on file affecting Oklahoma - 392 Oklahoma-specific plus 3375 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-04-15FDA-DeviceMedlineClass INationwideStop using affected Medline medical kits
Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
- 2026-04-15FDA-DeviceMedlineClass INationwideStop using Medline Special Procedure Tray kits
Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
- 2026-04-15FDA-DeviceMedlineClass INationwideStop using Medline NAMIC RA syringes immediately
Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
- 2026-04-15FDA-DeviceMedlineClass INationwideNAMIC Angiographic Syringe, labeled as follows: 1. SYRINGE,20ML,CONTROL,-,PKG, Medline SKU 70075027; 2. SYRINGE,10ML,TR/FR,RA,W/RES, Medline SKU 70085007; 3. MTO,SYRINGE,10ML,TR/FG,RA,-,PKG, Medline SKU 70085107; 4. SYRINGE,12ML,TR/FR,RA,W/RES, Medline SKU 70087007; 5. MTO,SYRINGE,12ML,TR/FG,RA,W/RES, Medline SKU 70087107; 6. SYRINGE,12ML,TR/FR,RA,W/O,RES,-,PKG, Medline SKU 70088007; 7. SYRINGE,10ML,PP/FR,RA,-,PKG, Medline SKU 70095007; 8. SYRINGE,10ML,PP/FG,RA,-,PKG, Medline SKU 70095107; 9. SY
Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
- 2026-04-15FDA-DeviceMedlineClass INationwideStop using affected Medline angiographic syringes
Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
- 2026-04-15FDA-DeviceMedlineClass INationwideStop using recalled Medline catheter lab kits
Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
- 2026-04-15FDA-DeviceMedlineClass INationwideStop using affected Medline manifold kits
Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
- 2026-04-15FDA-DeviceMedlineClass INationwideMedline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringes), labeled as follows: CVOR ANGIOGRAPHY PACK-LF, Medline SKU DYNJ42367B
Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
- 2026-04-15FDA-DeviceMedlineClass INationwideStop using Medline NAMIC angiographic syringes
Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
- 2026-04-15FDA-DeviceMedlineClass INationwideStop using affected Medline angiographic syringes
Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
- 2026-04-15FDA-DeviceSiemensClass IINationwideContact Siemens about your ARTIS imaging system
During patient examinations, the system may sporadically display a major increase of the x-ray dose applied to the patient. Despite the reported dose showing significantly higher, the actual applied x-ray dose levels are in accordance with the system settings and imaging conditions, as well as the applicable regulatory requirements.
- 2026-04-15FDA-DrugTevaClass IINationwideStop using recalled Teva Clonidine patches
CGMP Deviations: use of an unapproved raw material
- 2026-04-15FDA-DrugTevaClass IINationwideCheck your Clonidine patch lot numbers
CGMP Deviations: use of an unapproved raw material
- 2026-04-15FDA-DrugTevaClass IINationwideStop using recalled Teva Clonidine patches
CGMP Deviations: use of an unapproved raw material
- 2026-04-15FDA-DrugGE HealthcareClass IINationwideCheck Omnipaque injection lot numbers immediately
Presence of particulate matter
- 2026-04-15FDA-DrugGE HealthcareClass IINationwideCheck GE Healthcare Omnipaque injection lot numbers
Presence of particulate matter
- 2026-04-15FDA-DrugViatris, Inc.Class IINationwideCheck your Xanax XR 3 mg prescription bottle
Failed Dissolution Specifications
- 2026-04-15FDA-DrugPreferred Pharmaceuticals, Inc.Class IINationwideStop using Preferred Pharmaceuticals Artificial Tears
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFagron Compounding ServicesClass IINationwideStop using Fagron Vancomycin HCL IV bags
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- 2026-04-15FDA-DrugFagron Compounding ServicesClass IINationwideVancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- 2026-04-15FDA-DrugFagronClass IINationwideVancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5083-01
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- 2026-04-15FDA-DrugFagron Compounding ServicesClass IINationwideStop using Fagron norepinephrine injection
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- 2026-04-15FDA-DrugFagron Compounding ServicesClass IINationwideDo not use Fagron norepinephrine injection
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- 2026-04-15FDA-DrugFresenius KabiClass IINationwideStop using Fresenius Kabi dextrose injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius KabiClass IINationwideDo not use Fresenius Kabi dextrose injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius KabiClass IINationwideStop using Fresenius Kabi dextrose injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius KabiClass IINationwideStop using Fresenius Kabi sodium chloride injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius KabiClass IINationwideStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius KabiClass IINationwideStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius KabiClass IINationwide0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-05.
Lack of Assurance of Sterility
Get notified about new Oklahoma recalls
Free weekly digest. Add Oklahoma to your profile to filter alerts to your state.
Get the Sunday Brief